Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 6/2010

Open Access 01-12-2010 | Original Article

Neurocognitive functioning in school-aged cystinosis patients

Authors: M. T. P. Besouw, G. M. Hulstijn-Dirkmaat, R. E. A. van der Rijken, E. A. M. Cornelissen, C. M. van Dael, J. Vande Walle, M. R. Lilien, E. N. Levtchenko

Published in: Journal of Inherited Metabolic Disease | Issue 6/2010

Login to get access

Abstract

Introduction

Cystinosis is an autosomal recessive disorder leading to intralysosomal cystine accumulation in various tissues. It causes renal Fanconi syndrome and end stage renal failure around the age of 10 years if not treated with cysteamine. Children with cystinosis seem to have a normal intelligence but frequently show learning difficulties. These problems may be due to specific neurocognitive deficits rather than impaired renal function. Whether cysteamine treatment can improve cognitive functioning of cystinosis patients is thus far unknown. We aim to analyze neurocognitive functioning of school-aged cystinosis patients treated with cysteamine in order to identify specific deficits that can lead to learning difficulties.

Patients and methods

Fourteen Dutch and Belgian school-aged cystinosis patients were included. Glomerular filtration rate was estimated using the Schwartz formula. Children were tested for general intelligence, visual-motor integration, inhibition, interference, sustained attention, accuracy, planning, visual memory, processing speed, motor planning, fluency and speed, and behavioural and emotional functioning using standardized methods.

Results

Glomerular filtration rate ranged from 22 to 120 ml min−1 1.73 m−2. Median full-scale intelligence was below the average of a normal population (87, range 60–132), with a discrepancy between verbal (median 95, range 60–125) and performance (median 87, range 65–130) intelligence. Over 50% of the patients scored poorly on visual-motor integration, sustained attention, visual memory, planning, or motor speed. The other tested areas showed no differences between patients’ and normal values.

Conclusion

Neurocognitive diagnostics are indicated in cystinosis patients. Early recognition of specific deficits and supervision from special education services might reduce learning difficulties and improve school careers.

Literature
  1. Achenbach TM (1991) Manual for the child behavior checklist/4-18 and 1991 profile. University of Vermont, Department of Psychiatry, Burlington
  2. Ballantyne AO, Scarvie KM, Trauner DA (1997) Academic achievement in individuals with infantile nephropathic cystinosis. Am J Med Genet 74:157–161View ArticlePubMed
  3. Bava S, Theilmann RJ, Sach M et al. (2010) Developmental changes in cerebral white matter microstructure in a disorder of lysosomal storage. Cortex 46:206–216View ArticlePubMed
  4. Beery KE (1997) The Beery-Buktenica VMI. Developmental test of visual-motor integration: administration, scoring, and teaching manual, 4th edn. Modern Curriculum, Parsippany, NJ
  5. Bernstein JH, Waber DP (1996) Developmental scoring system for the Rey Osterrieth complex figure. Psychological Assessment Resources, Odessa
  6. Colah S, Trauner DA (1997) Tactile recognition in infantile nephropathic cystinosis. Dev Med Child Neurol 39:409–413View ArticlePubMed
  7. Delgado G, Schatz A, Nichols S, Appelbaum M, Trauner D (2005) Behavioral profiles of children with infantile nephropathic cystinosis. Dev Med Child Neurol 47:403–407View ArticlePubMed
  8. Gahl WA, Thoene JG, Schneider JA (2002) Cystinosis. N Engl J Med 347:111–121View ArticlePubMed
  9. Gipson DS, Wetherington CE, Duquette PJ, Hooper SR (2004) The nervous system and chronic kidney disease in children. Pediatr Nephrol 19:832–839View ArticlePubMed
  10. Hammes JGW (1978) De Stroop Kleur-woord test, handleiding. Swets & Zeitlinger, Lisse
  11. Jonas AJ, Conley SB, Marshall R, Johnson RA, Marks M, Rosenberg H (1987) Nephropathic cystinosis with central nervous system involvement. Am J Med 83:966–970View ArticlePubMed
  12. Kort W, Schittekatte M, Compaan EL et al. (2002) Wechsler Intelligence Scale for Children, derde editie NL. Psychological Corporation, London
  13. Lavigne JV, Faier-Routman J (1992) Psychological adjustment to pediatric physical disorders: a meta-analytic review. J Pediatr Psychol 17:133–157View ArticlePubMed
  14. Maurice T, Hippert C, Serratrice N et al. (2009) Cystine accumulation in the CNS results in severe age-related memory deficits. Neurobiol Aging 30:987–1000View ArticlePubMed
  15. Perrin EC, Stein RE, Drotar D (1991) Cautions in using the Child Behavior Checklist: observations based on research about children with a chronic illness. J Pediatr Psychol 16:411–421View ArticlePubMed
  16. Pinto JT, Khomenko T, Szabo S et al. (2009) Measurement of sulfur-containing compounds involved in the metabolism and transport of cysteamine and cystamine. Regional differences in cerebral metabolism. J Chromatogr B 877:3434–3441View Article
  17. Schoemaker MM, Schellekens JMH, Kalverboer AF, Kooistra L (1994) Pattern drawing by clumsy children: a problem of movement control? In: Simner ML, Hulstijn W, Girouard PL (eds) Contemporary issues in the forensic, developmental and neurological aspects of handwriting. AFDE, Toronto, pp 45–64
  18. Schwartz GJ, Munoz A, Schneider MF et al. (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637View ArticlePubMed
  19. Spilkin AM, Ballantyne AO, Babchuck LR, Trauner DA (2007) Non-verbal deficits in young children with a genetic metabolic disorder: WPPSI-III performance in cystinosis. Am J Med Genet B Neuropsychiatr Genet 144:444–447
  20. Spilkin AM, Ballantyne AO, Trauner DA (2009) Visual and verbal learning in a genetic metabolic disorder. Neuropsychologia 47:1883–1892View ArticlePubMed
  21. Town M, Jean G, Cherqui S et al. (1998) A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat Genet 18:319–324View ArticlePubMed
  22. Trauner DA, Chase C, Scheller J, Katz B, Schneider JA (1988) Neurologic and cognitive deficits in children with cystinosis. J Pediatr 112:912–914View ArticlePubMed
  23. Ulmer FF, Landolt MA, Vinh RH et al. (2009) Intellectual and motor performance, quality of life and psychosocial adjustment in children with cystinosis. Pediatr Nephrol 24:1371–1378View ArticlePubMed
  24. Verhulst FC, Van der Ende J, Koot HM (1996) Handleiding voor de CBCL/4-18. Department for Child and Adolescent Psychiatry, Erasmus MC-Sophia Children's Hospital, Rotterdam
  25. Verhulst FC, Van der Ende J, Koot HM (1997a) Handleiding voor de Teacher's Report Form (TRF). Department for Child and Adolescent Psychiatry, Erasmus MC-Sophia Children's Hospital, Rotterdam
  26. Verhulst FC, Van der Ende J, Koot HM (1997b) Handleiding voor de Youth Self-Report (YSR). Department for Child and Adolescent Psychiatry, Erasmus MC-Sophia Children's Hospital, Rotterdam
  27. Vogel DG, Malekzadeh MH, Cornford ME, Schneider JA, Shields WD, Vinters HV (1990) Central nervous system involvement in nephropathic cystinosis. J Neuropathol Exp Neurol 49:591–599View ArticlePubMed
  28. Vos PG (1998) Bourdon Vos test, handleiding. Swets & Zeitlinger, Lisse
  29. Wamelink MM, Struys EA, Jansen EE et al. (2008) Sedoheptulokinase deficiency due to a 57-kb deletion in cystinosis patients causes urinary accumulation of sedoheptulose: elucidation of the CARKL gene. Hum Mutat 29:532–536View ArticlePubMed
  30. Wechsler D (1991) Wechsler intelligence scale for children, 3rd edn. Psychological Corporation, San Antonio
  31. Williams BL, Schneider JA, Trauner DA (1994) Global intellectual deficits in cystinosis. Am J Med Genet 49:83–87View ArticlePubMed
  32. Wolff G, Ehrich JH, Offner G, Brodehl J (1982) Psychosocial and intellectual development in 12 patients with infantile nephropathic cystinosis. Acta Paediatr Scand 71:1007–1011View ArticlePubMed
Metadata
Title
Neurocognitive functioning in school-aged cystinosis patients
Authors
M. T. P. Besouw
G. M. Hulstijn-Dirkmaat
R. E. A. van der Rijken
E. A. M. Cornelissen
C. M. van Dael
J. Vande Walle
M. R. Lilien
E. N. Levtchenko
Publication date
01-12-2010
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 6/2010
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-010-9182-7

Other articles of this Issue 6/2010

Journal of Inherited Metabolic Disease 6/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine